This Biotech Company Wants the Power to Deny Patients Access to Their Own Genetic Information

<p><a href="https://www. avi icke.com/wp-co te t/ ploa s/2016/05/ge es.jpg" rel="attachme t wp-att-372826"><img class="size-f ll wp-image-372826 alig ce ter" src="https://www. avi icke.com/wp-co te t/ ploa s/2016/05/ge es.jpg" alt="ge es" wi th="600" height="398" srcset="https://www. avi icke.com/wp-co te t/ ploa s/2016/05/ge es-300×199.jpg 300w, https://www. avi icke.com/wp-co te t/ ploa s/2016/05/ge es.jpg 600w" sizes="(max-wi th: 709px) 85vw, (max-wi th: 909px) 67vw, (max-wi th: 984px) 61vw, (max-wi th: 1362px) 45vw, 600px" /></a></p>
<p>‘The biotech ology compa y Myria Ge etics is i famo s for pate ti g the BRCA1 a BRCA2 ge es—which are associate with breast, ovaria a prostate ca cers—a the si g the pate ts to establish a mo opoly o research a preve t other laboratories from testi g patie ts for i crease risk.</p>
<p>While the compa y was force to halt these practices i 2013 by the S preme Co rt, which r le that it is ot lawf l to pate t h ma ge etic material, Myria faces a fresh laws it over charges that it is illegally e yi g its clie ts access to their ow ge etic i formatio .’</p>
<p><a href="http://www.alter et.org/perso al-health/biotech-compa y-wa ts-power- e y-patie ts-access-their-ow -ge etic-i formatio " target="_bla k">Rea more: This Biotech Compa y Wa ts the Power to De y Patie ts Access to Their Ow Ge etic I formatio </a></p>